120 related articles for article (PubMed ID: 9506438)
1. Chromosomal allele loss in primary cutaneous melanoma is heterogeneous and correlates with proliferation.
Böni R; Matt D; Voetmeyer A; Burg G; Zhuang Z
J Invest Dermatol; 1998 Mar; 110(3):215-7. PubMed ID: 9506438
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity on chromosome 1 and 9 and hormone receptor analysis of metastatic malignant melanoma presenting in breast.
Beaty MW; Quezado M; Sobel ME; Duray P; Merino MJ
Int J Surg Pathol; 2005 Jan; 13(1):9-18. PubMed ID: 15735850
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of allelic deletions within melanoma metastases.
Bogdan I; Xin H; Burg G; Böni R
Melanoma Res; 2001 Aug; 11(4):349-54. PubMed ID: 11479423
[TBL] [Abstract][Full Text] [Related]
5. Clonal heterogeneity in sporadic melanomas as revealed by loss-of-heterozygosity analysis.
Takata M; Morita R; Takehara K
Int J Cancer; 2000 Feb; 85(4):492-7. PubMed ID: 10699920
[TBL] [Abstract][Full Text] [Related]
6. Uveal melanocytomas: genetic comparison with uveal and dermal melanomas.
Fogt F; Selim AM; Xu GX; Prinz MK; Eagle RC; Budimlija ZM
Arch Ophthalmol; 2005 Mar; 123(3):377-80. PubMed ID: 15767481
[TBL] [Abstract][Full Text] [Related]
7. Ultraviolet-induced acute histological changes in irradiated nevi are not associated with allelic loss.
Böni R; Matt D; Burg G; Tronnier M; Vortmeyer A; Zhuang Z
Arch Dermatol; 1998 Jul; 134(7):853-6. PubMed ID: 9681349
[TBL] [Abstract][Full Text] [Related]
8. Clonal relationships between epidermotropic metastatic melanomas and their primary lesions: a loss of heterozygosity and X-chromosome inactivation-based analysis.
Bahrami S; Cheng L; Wang M; Jones TD; Malone JC; Billings SD
Mod Pathol; 2007 Aug; 20(8):821-7. PubMed ID: 17571079
[TBL] [Abstract][Full Text] [Related]
9. CDKN2A mutation and deletion status in thin and thick primary melanoma.
Cachia AR; Indsto JO; McLaren KM; Mann GJ; Arends MJ
Clin Cancer Res; 2000 Sep; 6(9):3511-5. PubMed ID: 10999737
[TBL] [Abstract][Full Text] [Related]
10. Genotypic analysis of primary and metastatic cutaneous melanoma.
Rao UN; Jones MW; Finkelstein SD
Cancer Genet Cytogenet; 2003 Jan; 140(1):37-44. PubMed ID: 12550756
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas.
Lee JY; Finkelstein S; Hamilton RL; Rekha R; King JT; Omalu B
Neurosurgery; 2004 Nov; 55(5):1163-73. PubMed ID: 15509323
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity analysis of cutaneous melanoma and benign melanocytic nevi: laser capture microdissection demonstrates clonal genetic changes in acquired nevocellular nevi.
Maitra A; Gazdar AF; Moore TO; Moore AY
Hum Pathol; 2002 Feb; 33(2):191-7. PubMed ID: 11957144
[TBL] [Abstract][Full Text] [Related]
13. Allelic deletion at 9p21-22 in primary cutaneous CD30(+) large cell lymphoma.
Böni R; Xin H; Kamarashev J; Utzinger E; Dummer R; Kempf W; Kutzner H; Burg G
J Invest Dermatol; 2000 Dec; 115(6):1104-7. PubMed ID: 11121148
[TBL] [Abstract][Full Text] [Related]
14. Hereditary cutaneous melanoma.
Platz A; Ringborg U; Hansson J
Semin Cancer Biol; 2000 Aug; 10(4):319-26. PubMed ID: 10966854
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite analysis at 1p36.3 in malignant melanoma of the skin: fine mapping in search of a possible tumour suppressor gene region.
Poetsch M; Dittberner T; Woenckhaus C
Melanoma Res; 2003 Feb; 13(1):29-33. PubMed ID: 12569282
[TBL] [Abstract][Full Text] [Related]
16. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of allelic losses in primary melanoma.
Healy E; Belgaid C; Takata M; Harrison D; Zhu NW; Burd DA; Rigby HS; Matthews JN; Rees JL
Oncogene; 1998 Apr; 16(17):2213-8. PubMed ID: 9619830
[TBL] [Abstract][Full Text] [Related]
18. TTC4, a novel candidate tumor suppressor gene at 1p31 is often mutated in malignant melanoma of the skin.
Poetsch M; Dittberner T; Cowell JK; Woenckhaus C
Oncogene; 2000 Nov; 19(50):5817-20. PubMed ID: 11126369
[TBL] [Abstract][Full Text] [Related]
19. Melanoma ex naevo: a study of the associated naevus.
Bogdan I; Smolle J; Kerl H; Burg G; Böni R
Melanoma Res; 2003 Apr; 13(2):213-7. PubMed ID: 12690309
[TBL] [Abstract][Full Text] [Related]
20. X inactivation, DNA deletion, and microsatellite instability in common acquired melanocytic nevi.
Indsto JO; Cachia AR; Kefford RF; Mann GJ
Clin Cancer Res; 2001 Dec; 7(12):4054-9. PubMed ID: 11751501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]